Edition:
United Kingdom

People: Achillion Pharmaceuticals Inc (ACHN.OQ)

ACHN.OQ on NASDAQ Stock Exchange Global Select Market

4.74USD
21 Aug 2019
Change (% chg)

-- (--)
Prev Close
$4.74
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
418,492
52-wk High
$5.02
52-wk Low
$1.29

Vitullo, Nicole 

Ms. Nicole Vitullo serves as Independent Chairman of the Board of Achillion Pharmaceuticals Inc., since September 2010. Ms. Vitullo joined Domain Associates, a venture capital firm with an exclusive focus on life sciences, in 1999 and became a Partner in 2004. In addition to her investment responsibilities, she is involved in the distribution/liquidation strategies for the public companies in Domain’s Venture Capital portfolios. Ms. Vitullo is on the Board of Directors of Antios Therapeutics, Inc. (since November 2018) and Celtaxsys, Inc. (since June 2015), privately-held life sciences companies and serves on the Boards of Directors of Esperion Pharmaceuticals, Inc. (since April 2008) and Marinus Pharmaceuticals, Inc., (since September 2005) both publicly traded pharmaceutical companies. Ms. Vitullo previously served on the Board of Directors of Celator, Inc. (from April 2005 until July 2016) which was acquired by Jazz Pharmaceuticals plc in May 2016, and Durata Therapeutics, Inc., (from December 2009 until November 2014) which was sold to Actavis Plc in November 2014. From 1992 through 1999, Ms. Vitullo was Senior Vice President at Rothschild Asset Management, Inc. where she had responsibility for the U.S. public market investments of International Biotechnology Trust plc and Biotechnology Investments Limited. From 1991 to 1992, Ms. Vitullo served as the Director of Corporate Communications and Investor Relations at Cephalon, a publicly traded biotechnology company. Prior to Cephalon, Ms. Vitullo spent 12 years at Eastman Kodak, most recently in Corporate Development where she was involved in the development and management of Eastman Kodak’s venture capital activities. Ms. Vitullo received a B.A. and M.B.A. from the University of Rochester.

Basic Compensation

Total Annual Compensation, USD 65,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 60,600
Fiscal Year Total, USD 125,600

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Nicole Vitullo

125,600

Joseph Truitt

3,275,990

Brian Di Donato

--

Paul Firuta

1,098,700

Martha Manning

868,678

Anthony Gibney

1,064,960
As Of  31 Dec 2018